Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$228.26 - $319.04 $501,258 - $700,611
2,196 New
2,196 $700 Million
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $582,293 - $682,411
2,749 New
2,749 $621 Million
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $134,183 - $173,987
630 Added 26.69%
2,990 $670 Million
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $486,042 - $661,814
2,360 New
2,360 $656 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Inceptionr LLC Portfolio

Follow Inceptionr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.